Updated:
rEVO Biologics, Inc.
rEVO Biologics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000904973, and its reported industry is...
Overview
rEVO Biologics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000904973, and its reported industry is Biological Products, (No Diagnostic Substances). The retained history contains 12 filings, including S-1 filed on 2014-06-25. Each filing retains its accession, filing date and original SEC document link. This historical evidence does not establish current registration, listing, ownership or financial condition.
Company overview
- Legal name
- rEVO Biologics, Inc.
- Former names in filing history
- GTC BIOTHERAPEUTICS INC (2002-06-03 to 2010-12-15); GENZYME TRANSGENICS CORP (1996-06-12 to 2002-04-18)
- Classification
- Company
- Industry (SIC)
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters
- Framingham, MA, United States
- Incorporated in
- MA
- Fiscal year end
- December 31
- SEC CIK
- 0000904973
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| S-1 | — | FORM S-1 | |
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research rEVO Biologics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.